UNSPSC 41181549: Beta-2-microglobulin immunological test system

In this classification, a Beta-2-microglobulin immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Beta-2-microglobulin. US FDA regulates Beta-2-microglobulin immunological test system under 21 CFR 866.5630 and under FDA product code JZG.

UNSPSC 41181549 Beta-2-microglobulin immunological test system is a Commodity code, but the recent state and local opportunities tagged under it reflect a much broader scope of laboratory testing, equipment maintenance, and diagnostic instrumentation procurement than the code's narrow name suggests. State and local governments are actually buying laboratory testing services for clinical and custodial populations, repair and maintenance contracts for specialized laboratory equipment, spectrophotometers and analytical instruments for water quality and waste-to-energy operations, oil analysis and transformer diagnostics for utility operations, and information management systems for public health labs. The issuing bodies span county corrections departments, state health agencies, municipal utilities, transit authorities, and regional water authorities—a diverse mix reflecting distributed laboratory and diagnostic infrastructure across multiple service lines rather than centralized procurement.

Recent opportunities show activity across multiple regions with no single geographic concentration. Marion County, Oregon solicited laboratory testing and phlebotomy services (ITB SO1814-26, due July 24, 2026); Texas Department of State Health Services procured annual equipment repair and maintenance for laboratory instruments at its South Texas Laboratory in Harlingen (IFB HHS0017421, due July 6, 2026, with historical annual values ranging from $25,050 to $40,000); City of Tampa sought a replacement Heck DR4900 spectrophotometer for its McKay Bay Waste to Energy facility (RFQ 26-P-00372); Lubbock Power & Light requested annual insulating oil testing laboratory services across approximately 20 substations (RFP 713126ELD, due July 22, 2026); and County of Santa Clara issued an RFI for a public health lab information management system replacement (RFITSSFY260686, due April 22, 2026). The code shows activity in Oregon, Texas, Florida, and California, but the opportunities are functionally diverse enough that pursuit should be qualified by actual capability alignment with the specific service or instrument category rather than assumption that Beta-2-microglobulin immunological testing directly applies.